中国组织工程研究

中国组织工程研究 ›› 2011, Vol. 15 ›› Issue (38): 7197-7200.doi: 10.3969/j.issn.1673-8225.2011.38.040

• 生物材料学术探讨 biomaterial academic discussion • 上一篇    下一篇

抗肿瘤缓释剂在肝癌介入治疗中的应用

潘彦康，黄  敏，刘裕恒   

  1. 广西壮族自治区人民医院临床肿瘤中心介入科，广西壮族自治区南宁市  315700
  • 收稿日期:2011-05-05 修回日期:2011-08-12 出版日期:2011-09-17 发布日期:2011-09-17
  • 作者简介:潘彦康，男，1966年生，广西壮族自治区罗城县人，仫佬族，1991年广西医学院毕业，主治医师，主要从事肿瘤介入治疗的研究。 longtenhe1965@yahoo.com.cn

Sustained-release anti-tumor agent in interventional treatment of liver cancer

Pan Yan-kang, Huang Min, Liu Yu-heng   

  1. Department of Intervention, Clinical Tumor Center, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning  315700, Guangxi Zhuang Autonomous Region, China
  • Received:2011-05-05 Revised:2011-08-12 Online:2011-09-17 Published:2011-09-17
  • About author:Pan Yan-kang, Attending physician, Department of Intervention, Clinical Tumor Center, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 315700, Guangxi Zhuang Autonomous Region, China longtenhe1965@ yahoo.com.cn

PDF

356

被引次数

3

摘要：

背景：肿瘤内直接注入化疗缓释剂为肿瘤的治疗提供了一个新的途径。
目的：评价抗肿瘤缓释剂在肝癌中应用，寻找合理的治疗方案。
方法：以 “肝癌，植入化疗，缓释植入剂，化学药物为中文关键词；以“liver cancer, implantation of chemotherapy, sustained release implants, chemicals” 为英文关键词。采用计算机检索1993-01/2010-12相关文章。纳入与有关生物材料与组织工程血管相关的文章；排除重复研究或Meta分析类文章。以29篇文献为主重点进行了讨论抗肿瘤缓释剂在肝癌中应用。
结果与结论：植入肝癌中瘤内或肿瘤手术中植入残留灶及可能有微小转移瘤灶区域的化疗缓释植入剂，既提高了肿瘤局部药物浓度及作用时间，同时也降低或避免了全身化疗常见的毒副反应，为肿瘤的化学治疗提供了一条新的给药途径；肿瘤内直接注入化疗缓释剂也为一些失去手术、放疗或不能耐受全身化疗的晚期肿瘤患者减少痛苦和带来新的希望。抗肿瘤缓释剂可作为一种较理想的缓释植入剂应用于肝癌中的化疗药物。

关键词: 缓释剂, 肝癌, 植入化疗, 缓释植入剂, 化学药物

Abstract:

BACKGROUND: Direct injection of sustained-release chemotherapy provides a new way to tumor treatment.
OBJECTIVE: To evaluate the application of sustained-release anti-tumor agents in liver cancer and to find a reasonable treatment.
METHODS: A computer based search of relevant articles published 1993-01/2010-12 were retrieved by using the keywords of “liver cancer, implantation of chemotherapy, sustained release implants, chemicals” in Chinese and English. Repetitive articles and Meta analysis were excluded, and finally 29 articles were included in result analysis.
RESULTS AND CONCLUSION: Direct injection of sustained-release chemotherapy improves local tumor drug concentration and reaction time, and reduces or avoids systemic chemotherapy-induced common side effects, providing a new route of administration. Direct injection of sustained-release chemotherapy also relieves the pain of advanced cancer patients, bringing a new hope. Sustained-release anti-tumor agents can be used as an ideal slow-release implant in the chemotherapy drugs used in the treatment of liver cancer.

中图分类号: